The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 of EO2463 immunotherapy as monotherapy and in combination with lenalidomide and/or rituximab in indolent NHL (EONHL1-20/SIDNEY).
 
Jose Caetano Villasboas
Consulting or Advisory Role - Curio Science (Inst); Kite/Gilead (Inst); Regeneron (Inst); TG Therapeutics (Inst)
Research Funding - Aptose Biosciences (Inst); Enterome (Inst); Epizyme (Inst); Genentech/Roche (Inst); Regeneron (Inst)
 
Danielle Wallace
Honoraria - Elsevier; Gather-ed
 
Stephen Douglas Smith
Consulting or Advisory Role - Abbvie; BeiGene; Coherus Biosciences (I); Genentech; Incyte; Kite, a Gilead company; Lumanity; Numab
Research Funding - Acerta Pharma/AstraZeneca (Inst); ADC Therapeutics (Inst); Ayala Pharmaceuticals (I); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (I); Denovo Biopharma (Inst); Enterome (Inst); Genentech (Inst); Ignyta (I); Incyte (Inst); Kymera (Inst); Merck (Inst); MorphoSys/Incyte (Inst); Nanjing (Inst); Viracta Therapeutics (Inst)
 
Carlos Grande
Consulting or Advisory Role - Abbvie; Amgen; Incyte; Lilly; Roche
Research Funding - Roche
 
Jean pierre Marolleau
No Relationships to Disclose
 
Francesc Bosch
Honoraria - Abbvie; Advantage Pharmaceuticals; ASCEND Therapeutics; AstraZeneca; BeiGene; BMS GmbH & Co. KG; Johnson & Johnson/Janssen; Lilly; Merck; Novartis; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Janssen-Cilag; Kite, a Gilead company; Lilly; Novartis; Roche/Genentech
Speakers' Bureau - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene; Janssen; Johnson & Johnson/Janssen; Kite/Gilead; Merck; Roche
Research Funding - AstraZeneca; Janssen
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BeiGene; Johnson & Johnson/Janssen
 
Antonio Pinto
Honoraria - Bristol-Myers Squibb/Celgene; Incyte; Merck Sharp & Dohme; Roche/Genentech; SERVIER
Consulting or Advisory Role - Merck; Roche/Genentech; Servier
Speakers' Bureau - Incyte; Roche
 
Luca Arcaini
Honoraria - Eusa Pharma; Novartis/Ipsen
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; EUSA Pharma; Incyte; Janssen-Cilag; Kite/Gilead; Kite/Gilead; Novartis; Roche
Speakers' Bureau - EUSA Pharma; Novartis
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Eusa Pharma; Janssen-Cilag; Roche
 
Reid Merryman
Consulting or Advisory Role - Abbvie; Alphasights; Alphasights; Bristol-Myers Squibb/Medarex; Epizyme; Intellia Therapeutics
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Genmab (Inst); Merck (Inst)
 
Ramón Garcia Sanz
Honoraria - Amgen; AstraZeneca Spain; Beigene; Janssen; Novartis; Takeda
Consulting or Advisory Role - Janssen
Research Funding - Astellas Pharma; Incyte (Inst); Takeda (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - BIOMED 2 primers (Inst)
Travel, Accommodations, Expenses - Janssen; Takeda (I)
Other Relationship - Spanish Society of Hematology
 
Pier Luigi Zinzani
Consulting or Advisory Role - ADC Therapeutics; BeiGene; Bristol-Myers Squibb; Celltrion; EUSA Pharma; Gilead Sciences; Incyte; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Novartis; Roche; Sandoz; Secura BIO; SERVIER; Takeda; TG Therapeutics
Speakers' Bureau - EUSA Pharma; MSD; Novartis
 
Lucie Aubergeon
Employment - Service d'Hématologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
Honoraria - BMS Brazil
 
Laurent Chêne
Employment - Enterome
 
Jan Fagerberg
Employment - Enterome
Leadership - Enterome
Stock and Other Ownership Interests - Enterome
Travel, Accommodations, Expenses - Enterome
 
Philippe Armand
Consulting or Advisory Role - ADC Therapeutics; ATB Therapeutics; Bristol-Myers Squibb; Enterome; Foresight Diagnostics; Genentech/Roche; GenMab; Merck Sharp & Dohme; Regeneron
Research Funding - Adaptive Biotechnologies; Adaptive Biotechnologies (Inst); Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); igm (Inst); Kite, a Gilead company (Inst); Merck Sharp & Dohme (Inst); Roche (Inst)
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)
 
Stephen M. Ansell
Honoraria - Answers in CME; Medscape; Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Step Pharma (Inst); Takeda (Inst)